glp 1 patient education Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs Updated guidance for patients using

Handling & Disclaimer FOR RESEARCH USE ONLY

Viking Therapeutics Sector: Dual and triple agonists for obesity, metabolic, and liver disease HQ: San Diego, CA Year Founded: 2012 Origin Story: The company built its pipeline around small molecule and peptide candidates licensed from academic and pharma sources, eventually advancing VK2735, a dual GLP-1/GIP receptor agonist designed to be the first such therapy available in both oral and injectable formulations

Typically, its a good idea to get a baseline DEXA scan before or at the start of your GLP-1 therapy

Third, protein protects lean muscle mass

For people concerned about blood sugar monitoring while on these medications, the GLP-1 and blood work guide explains what to expect from routine lab tests

However, Hers weight loss products are not yet available in all 50 states